Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone versus high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia
2008-000417-30Phase 3Terminated
- Sponsor
- GIMEMA
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in immune thrombocytopenia (ITP) comparing Standard-dose prednisone with High-dose dexamethasone (2 arms). Primary endpoint: Final response rate at day 180. Started Apr 2008; status: terminated.
02
Drugs
dexamethasoneprednisone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2008-000417-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000417-30.